Samsung Pharm GemVax present pancreatic cancer immunotherape...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, June 5, 2021 /PRNewswire-AsiaNet/ -- Samsung Pharm Co., Ltd. announced today that the company presented the results of a phase III clinical trial of its pancreatic cancer immunotherapeutic drug candidate called 'RIAVAX(TM) (GV1001)' conducted in Korea at the 2021 American Society of ...
Authors: LATEST ASIANET NEWS RELEASES